Tony Vahedian, CEO at CCS
A report from the Peterson Health Technology Institute (PHTI) found that many digital diabetes management platforms aren’t providing meaningful ROI for patients or the health system as a whole. Users of common…
Continue Reading
In 2023, the FDA identified 62 medical device recalls with 42 identified to date in 2024. Most recently, Tandem Diabetes Care recalled its Apple iOS app after over 200 reported injuries. While the issues…
Continue Reading
What You Should Know:
– Tandem Diabetes Care (TNDM) and Dexcom (DXCM) announced today that the Tandem Mobi insulin pump with Control-IQ technology is now compatible with both the Dexcom G7 and Dexcom G6 Continuous…
Continue Reading
What You Should Know:
– Senseonics Holdings, Inc., a provider of long-term implantable continuous glucose monitoring (CGM) systems, today announced a strategic partnership with Rimidi. Rimidi offers a comprehensive clinical management platform designed to improve…
Continue Reading
Too often, data collected from wearables and monitoring devices adds to the burden on healthcare professionals. Help in the form of a new information standard is on the way, writes Charlie McCayThe use of…
Continue Reading
By Anuja Vaidya
April 25, 2024 – Though telehealth can significantly improve diabetes care, new research shows several gaps that must be closed through strategies such as creating efficient workflows around scheduling follow-up visits and ensuring…
Continue Reading
Putting the patient at the centre when digitalising systems and processes is a must, speaker told a session on the Patient Engagement stage at Rewired24 Wednesday. The key is to communicate with patients through…
Continue Reading
What You Should Know:
– Medicare has significantly expanded access to the Eversense E3 continuous glucose monitoring (CGM) System, a long-lasting and implantable option that offers several advantages over traditional CGMs.
– Medicare has significantly expanded…
Continue Reading
What You Should Know:
Valendo Health, a value-based endocrinology company, officially launched today with a mission to empower endocrinologists to shape the future of diabetes care.The company launches with two provider partners already onboard, including Cecelia…
Continue Reading
Valendo Health, a diabetes-focused, value-based endocrinology company, announced its launch with $4 million in seed funding and two providers. The company, built out of Redesign Health, aims to increase revenue for endocrinologists while assisting with…
Continue Reading
